RDRamón Angel Durazo-Arvizu

Ramón Angel Durazo-Arvizu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ramón Angel Durazo-Arvizu has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association between 25-Hydroxyvitamin D and Intact Parathyroid Hormone Levels Across Latitude among Adults with African Ancestry

    by Holly Kramer, Pauline Camacho, John Aloia, Amy Luke, Pascal Bovet, Jacob Plange Rhule, Terrence Forrester, Vickie Lambert, Regina Harders, Lara Dugas, et al.


  • Open Access

    Impact of alternative approaches to assess outlying and influential observations on health care costs

    by Thomas Weichle, Denise M Hynes, Ramon Durazo-Arvizu, Elizabeth Tarlov, Qiuying Zhang

    The distributions of medical costs are often skewed to the right because small numbers of patients use large amounts of health care resources. Using data from a study of colon cancer costs, we show, by example, the impact and magnitude of outliers and influential observations on health care costs and compared the effects of statistical costing methods for addressing the disproportionate influence of outliers and influential observations. We used data from a retrospective cohort study of 3,842 elderly veterans with colon cancer who were enrolled in and used health care from, both the Department of Veterans Affairs and Medicare in 1999–2004. After calculating the average colon cancer episode cost and distribution for the full cohort, we used box-plot methods, Winsorization, DFBETAs, and Cook's distance to identify and assess or adjust the outlying and/or influential observations. The number of observations identified as outlying and/or influential ranged from 13 when the predicted DFBETA measurement was greater than 0.15 and the observation was a qualified box-plot outlier to 384 cases using the Winsorization method at the 5th and 95th percentiles. Average costs of colon cancer episodes using these methods were similar. The method of choice from the results of this particular analysis can be conditionally based on whether the purpose is to control only for influential observations or to simultaneously control for outliers and influential observations. Understanding how estimates could change with each approach is important in assessing the impact of a particular method on the results.


  • Open Access

    Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk

    by Amy Luke, Pascal Bovet, Terrence E Forrester, Estelle V Lambert, Jacob Plange-Rhule, Dale A Schoeller, Lara R Dugas, Ramon A Durazo-Arvizu, David Shoham, Richard S Cooper, et al.

    The prevalence of obesity has increased in societies of all socio-cultural backgrounds. To date, guidelines set forward to prevent obesity have universally emphasized optimal levels of physical activity. However there are few empirical data to support the assertion that low levels of energy expenditure in activity is a causal factor in the current obesity epidemic are very limited. The Modeling the Epidemiologic Transition Study (METS) is a cohort study designed to assess the association between physical activity levels and relative weight, weight gain and diabetes and cardiovascular disease risk in five population-based samples at different stages of economic development. Twenty-five hundred young adults, ages 25-45, were enrolled in the study; 500 from sites in Ghana, South Africa, Seychelles, Jamaica and the United States. At baseline, physical activity levels were assessed using accelerometry and a questionnaire in all participants and by doubly labeled water in a subsample of 75 per site. We assessed dietary intake using two separate 24-hour recalls, body composition using bioelectrical impedance analysis, and health history, social and economic indicators by questionnaire. Blood pressure was measured and blood samples collected for measurement of lipids, glucose, insulin and adipokines. Full examination including physical activity using accelerometry, anthropometric data and fasting glucose will take place at 12 and 24 months. The distribution of the main variables and the associations between physical activity, independent of energy intake, glucose metabolism and anthropometric measures will be assessed using cross-section and longitudinal analysis within and between sites. METS will provide insight on the relative contribution of physical activity and diet to excess weight, age-related weight gain and incident glucose impairment in five populations' samples of young adults at different stages of economic development. These data should be useful for the development of empirically-based public health policy aimed at the prevention of obesity and associated chronic diseases.


  • Open Access

    Assessing Physical Activity and its Relationship to Cardiovascular Risk Factors: NHANES 2003-2006

    by Amy Luke, Lara R Dugas, Ramon A Durazo-Arvizu, Guichan Cao, Richard S Cooper

    Levels of physical activity (PA) in the general population are difficult to characterize. Historically measurement has been based on self-report, which can be subject to bias. PA monitor use has created opportunities to improve surveillance and analytic research on activity and health. The aims of the current study were to investigate the associations between objectively measured PA and cardiovascular disease risk factors and obesity.


  • Open Access

    Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia

    by Vicente Gil-Guillen, Domingo Orozco-Beltran, Josep Redon, Salvador Pita-Fernandez, Jorge Navarro-Pérez, Vicente Pallares, Francisco Valls, Carlos Fluixa, Antonio Fernandez, Jose M Martin-Moreno, et al.

    Background: The Escarval-Risk study aims to validate cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia living in the Valencia Community, a European Mediterranean region, based on data from an electronic health recording system comparing predicted events with observed during 5 years follow-up study. Methods/Design: A cohort prospective 5 years follow-up study has been designed including 25000 patients with hypertension, diabetes and/or dyslipidemia attended in usual clinical practice. All information is registered in a unique electronic health recording system (ABUCASIS) that is the usual way to register clinical practice in the Valencian Health System (primary and secondary care). The system covers about 95% of population (near 5 million people). The system is linked with database of mortality register, hospital withdrawals, prescriptions and assurance databases in which each individual have a unique identification number. Diagnoses in clinical practice are always registered based on IDC-9. Occurrence of CV disease was the main outcomes of interest. Risk survival analysis methods will be applied to estimate the cumulative incidence of developing CV events over time. Discussion: The Escarval-Risk study will provide information to validate different cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia from a low risk Mediterranean Region, the Valencia Community.


  • Issues related to modeling the body mass index–mortality association: the shape of the association and the effects of smoking status

    by R A Durazo-Arvizu, R S Cooper

    Research on the relationship between body mass index (BMI) and mortality has led to conflicting results; a lack of agreement about how to adjust for confounders, such as smoking status, has added to the problem. Complicating such analyses is the fact that the BMI–mortality association is not a symmetric quadratic relationship; the distribution tends to be skewed to the right, causing the optimal BMI—where mortality is at a minimum—to be overestimated. One way to overcome this problem is by transformation of the BMI distribution to normality. The authors suggest several approaches for doing so, including the use of 1/BMI, or lean body mass index, instead of BMI in modeling. Data sets on 50 cohorts from approximately 30 international studies were used to examine the association (direct, inverse, quadratic or none) between BMI and mortality and to investigate the possible interaction of smoking status. Of the 50 cohorts, 36 showed a quadratic association between BMI and mortality, 10 showed no association and 1 showed a direct association between lean BMI and mortality. Only three cohorts showed a significant interaction between BMI and smoking, which was approximately what one would expect from a 5% significance test, even if no interaction existed. The association between BMI and mortality is not changed when smoking status is ignored in a model or when data on smokers are excluded from analysis. The methodology used in this study could be extended to look for other interactions.


  • Open Access

    Rapid increases in obesity in Jamaica, compared to Nigeria and the United States

    by Ramón A Durazo-Arvizu, Amy Luke, Richard S Cooper, Guichan Cao, Lara Dugas, Adebowale Adeyemo, Michael Boyne, Terrence Forrester

    Weight gain in adulthood is now common in many populations, ranging from modest gains in developing countries to a substantial percentage of body weight in some Western societies. To examine the rate of change across the spectrum of low to high-income countries we compared rates of weight change in samples drawn from three countries, Nigeria, Jamaica and the United States.


  • Hypertension in Mexico and among Mexican Americans: prevalence and treatment patterns

    by S Barquera, R A Durazo-Arvizu, A Luke, G Cao, R S Cooper

    Increased social and economic integration across the US–Mexican borders has led to important new developments in public health. Lower levels of cardiovascular mortality have been observed among Mexican Americans (MAs) although few direct comparisons have been undertaken with Mexico. Using survey data in the respective countries we examined blood pressure (BP) levels, hypertension prevalence and patterns of awareness, treatment and control in Mexico and among MAs. A national representative sample of the adult population from Mexico collected in 2000 (N=49 294), and data on 8688 MA participants in the 1999–2004 National Health and Nutrition Examination survey from the United States were available for analysis. US-born MAs and those born in Mexico were analysed separately in the US data. Lack of direct standardization of methods between surveys necessitated statistical adjustment of BP values. Analyses were based on persons aged 25–64 in each country. Sex- and age-adjusted mean systolic/diastolic BPs were 122/80, 119/71 and 120/73 in Mexicans, immigrant MAs and US-born MAs, respectively. The prevalences of hypertension (BP140/90 or treatment) were 33, 17 and 22%. Hypertension control rates were 3.7, 32.1 and 37.9%, in the same groups. Awareness and treatment rates were 25 and 13% in Mexico and 54 and 46% among MAs in the United States, respectively. Hypertension appears to be more common in Mexico than among Mexican immigrants to the United States. Despite relatively low access to health insurance in the United States, hypertension control increased over the course of this migration.


  • Open Access

    Cardiovascular disease surveillance in Mexicans and Mexican Americans: a tale of two countries

    by Ramón Angel Durazo-Arvizu, Simon Barquera, Mariana Lazo-Elizondo, Manuel Franco, Richard S. Cooper